ML23195A065: Difference between revisions
StriderTol (talk | contribs) (StriderTol Bot insert) |
StriderTol (talk | contribs) (StriderTol Bot change) |
||
| Line 16: | Line 16: | ||
=Text= | =Text= | ||
{{#Wiki_filter:UNITED STATES NUCLEAR REGULATORY COMMISSION WASHINGTON, D.C. 20555-0001 | {{#Wiki_filter:UNITED STATES NUCLEAR REGULATORY COMMISSION WASHINGTON, D.C. 20555-0001 ALL AGREEMENT STATES CONNECTICUT, INDIANA, WEST VIRGINIA NOTICE OF EXTENSION OF COMMENT PERIOD FOR INFORMATION REQUEST REGARDING RULEMAKING ON THE REPORTING OF NUCLEAR MEDICINE INJECTION EXTRAVASATIONS AS MEDICAL EVENTS (STC-23-052) | ||
==Purpose:== | ==Purpose:== | ||
To provide notice that the comment period for the information request regarding the rulemaking on the reporting of nuclear medicine injection extravasations as medical events has been extended until September 1, 2023. | To provide notice that the comment period for the information request regarding the rulemaking on the reporting of nuclear medicine injection extravasations as medical events has been extended until September 1, 2023. | ||
==Background:== | ==Background:== | ||
On April 19, 2023, the U.S. Nuclear Regulatory Commission (NRC) published a Federal Register notice (FRN) (88 FR 24130) to make available preliminary proposed rule language and pose specific questions to stakeholders for a rulemaking on the reporting of nuclear medicine injection extravasations as medical events. The FRN included a 90-day comment period ending on July 18, 2023. On April 28, 2023, NRC provided notification of issuance of the above FRN in STC-23-033, Notification of Issuance of Federal Register Notice Requesting Information Regarding a Rulemaking on the Reporting of Nuclear Medicine Injection Extravasations as Medical Events (Agencywide Documents Access Management System (ADAMS) Accession No. ML23109A056). | On April 19, 2023, the U.S. Nuclear Regulatory Commission (NRC) published a Federal Register notice (FRN) (88 FR 24130) to make available preliminary proposed rule language and pose specific questions to stakeholders for a rulemaking on the reporting of nuclear medicine injection extravasations as medical events. The FRN included a 90-day comment period ending on July 18, 2023. On April 28, 2023, NRC provided notification of issuance of the above FRN in STC-23-033, Notification of Issuance of Federal Register Notice Requesting Information Regarding a Rulemaking on the Reporting of Nuclear Medicine Injection Extravasations as Medical Events (Agencywide Documents Access Management System (ADAMS) Accession No. ML23109A056). | ||
Discussion: The comment period has been extended until September 1, 2023. The FRN (88 FR 45824), published on July 18, 2023, describes how to submit comments and can be accessed at https://www.govinfo.gov/content/pkg/FR-2023-07-18/pdf/2023-15130.pdf. This FRN and the other FRN described in the Background section have been posted to https://www.regulations.gov under Docket No. NRC-2022-0218. The original FRN for the information request can be accessed at: https://www.govinfo.gov/content/pkg/FR-2023 19/pdf/2023-08238.pdf. | Discussion: The comment period has been extended until September 1, 2023. The FRN (88 FR 45824), published on July 18, 2023, describes how to submit comments and can be accessed at https://www.govinfo.gov/content/pkg/FR-2023-07-18/pdf/2023-15130.pdf. This FRN and the other FRN described in the Background section have been posted to https://www.regulations.gov under Docket No. NRC-2022-0218. The original FRN for the information request can be accessed at: https://www.govinfo.gov/content/pkg/FR-2023 19/pdf/2023-08238.pdf. | ||
More information on this rulemaking can be found on the NRCs public website at https://www.nrc.gov/materials/miau/med-use-toolkit/reporting-nuclear-medicine-injection-extravasations.html and at https://www.nrc.gov/reading-rm/doc-collections/rulemaking-ruleforum/active/ruledetails.html?id=2180. | More information on this rulemaking can be found on the NRCs public website at https://www.nrc.gov/materials/miau/med-use-toolkit/reporting-nuclear-medicine-injection-extravasations.html and at https://www.nrc.gov/reading-rm/doc-collections/rulemaking-ruleforum/active/ruledetails.html?id=2180.July 20, 2023 STC-23-052 2 If you have any questions regarding this correspondence, please contact me at Adeliade.Giantelli@nrc.gov, or the individual listed below: | ||
POINT OF CONTACT: Irene Wu EMAIL: Irene.Wu@nrc.gov TELEPHONE: (301) 415-1951 Adelaide Giantelli, Chief State Agreement and Liaison Programs Branch Division of Materials Safety, Security, State, and Tribal Programs Office of Nuclear Material Safety and Safeguards Signed by Giantelli, Adelaide on 07/20/23 | |||
ML23195A065 OFFICE NMSS/REFS NMSS/REFS/MRPB NMSS/MSST/MSEB NMSS/MSST/SMPB | |||
/MRPB JShepherd CEinberg NAME IWu IW GTartal for GT CValentin-Rodriguez AGiantelli AG for CV DATE Jul 18, 2023 Jul 19, 2023 Jul 18, 2023 Jul 20, 2023}} | |||
ML23195A065 NMSS/REFS | |||
Latest revision as of 18:44, 13 November 2024
| ML23195A065 | |
| Person / Time | |
|---|---|
| Issue date: | 07/20/2023 |
| From: | Adelaide Giantelli NRC/NMSS/DREFS/MRPB |
| To: | State of CT, State of IN, State of WV, State, Agreement States |
| References | |
| STC-23-052 | |
| Download: ML23195A065 (3) | |
Text
UNITED STATES NUCLEAR REGULATORY COMMISSION WASHINGTON, D.C. 20555-0001 ALL AGREEMENT STATES CONNECTICUT, INDIANA, WEST VIRGINIA NOTICE OF EXTENSION OF COMMENT PERIOD FOR INFORMATION REQUEST REGARDING RULEMAKING ON THE REPORTING OF NUCLEAR MEDICINE INJECTION EXTRAVASATIONS AS MEDICAL EVENTS (STC-23-052)
Purpose:
To provide notice that the comment period for the information request regarding the rulemaking on the reporting of nuclear medicine injection extravasations as medical events has been extended until September 1, 2023.
Background:
On April 19, 2023, the U.S. Nuclear Regulatory Commission (NRC) published a Federal Register notice (FRN) (88 FR 24130) to make available preliminary proposed rule language and pose specific questions to stakeholders for a rulemaking on the reporting of nuclear medicine injection extravasations as medical events. The FRN included a 90-day comment period ending on July 18, 2023. On April 28, 2023, NRC provided notification of issuance of the above FRN in STC-23-033, Notification of Issuance of Federal Register Notice Requesting Information Regarding a Rulemaking on the Reporting of Nuclear Medicine Injection Extravasations as Medical Events (Agencywide Documents Access Management System (ADAMS) Accession No. ML23109A056).
Discussion: The comment period has been extended until September 1, 2023. The FRN (88 FR 45824), published on July 18, 2023, describes how to submit comments and can be accessed at https://www.govinfo.gov/content/pkg/FR-2023-07-18/pdf/2023-15130.pdf. This FRN and the other FRN described in the Background section have been posted to https://www.regulations.gov under Docket No. NRC-2022-0218. The original FRN for the information request can be accessed at: https://www.govinfo.gov/content/pkg/FR-2023 19/pdf/2023-08238.pdf.
More information on this rulemaking can be found on the NRCs public website at https://www.nrc.gov/materials/miau/med-use-toolkit/reporting-nuclear-medicine-injection-extravasations.html and at https://www.nrc.gov/reading-rm/doc-collections/rulemaking-ruleforum/active/ruledetails.html?id=2180.July 20, 2023 STC-23-052 2 If you have any questions regarding this correspondence, please contact me at Adeliade.Giantelli@nrc.gov, or the individual listed below:
POINT OF CONTACT: Irene Wu EMAIL: Irene.Wu@nrc.gov TELEPHONE: (301) 415-1951 Adelaide Giantelli, Chief State Agreement and Liaison Programs Branch Division of Materials Safety, Security, State, and Tribal Programs Office of Nuclear Material Safety and Safeguards Signed by Giantelli, Adelaide on 07/20/23
ML23195A065 OFFICE NMSS/REFS NMSS/REFS/MRPB NMSS/MSST/MSEB NMSS/MSST/SMPB
/MRPB JShepherd CEinberg NAME IWu IW GTartal for GT CValentin-Rodriguez AGiantelli AG for CV DATE Jul 18, 2023 Jul 19, 2023 Jul 18, 2023 Jul 20, 2023